FY 2026 saw record revenue, cash generation, and market share gains, with Biome Daily becoming Australia's top probiotic. International expansion delivered high margins and strong growth, especially in Canada and Ireland, while new manufacturing and digital initiatives set the stage for accelerated growth in FY 2027.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.